1.
Frankel
AD
,
Pabo
CO
. Cellular uptake of the tat protein from human immunodeficiency virus . Cell.
1988; ; 55 : :1189.-1193.
2.
Joliot
A
,
Pernelle
C
,
Deagostini-Bazin
H
,
Prochiantz
A
. Antennapedia homeobox peptide regulates neural morphogenesis . Proc Natl Acad Sci USA.
1991; ; 88 : :1864.-1868.
3.
Derossi
D
,
Joliot
AH
,
Chassaing
G
,
Prochiantz
A
. The third helix of the antennapedia homeodomain translocates through biological membranes . J Biol Chem.
1994; ; 269 : :10444.-10450.
4.
Vives
E
,
Brodin
P
,
Lebleu
B
. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus . J Biol Chem.
1997; ; 272 : :16010.-16017.
5.
Esteve
E
,
Mabrouk
K
,
Dupuis
A
, et al.
Transduction of the scorpion toxin maurocalcine into cells. Evidence that the toxin crosses the plasma membrane . J Biol Chem.
2005; ; 280 : :12833.-12839.
6.
Fajloun
Z
,
Kharrat
R
,
Chen
L
, et al.
Chemical synthesis and characterization of maurocalcine, a scorpion toxin that activates Ca2+ release channel/ryanodine receptors . FEBS Lett.
2000; ; 469 : :179.-185.
7.
Altafaj
X
,
Cheng
W
,
Esteve
E
, et al.
Maurocalcine and domain A of the II-III loop of the dihydropyridine receptor Cav 1.1 subunit share common binding sites on the skeletal ryanodine receptor . J Biol Chem.
2005; ; 280 : :4013.-4016.
8.
Esteve
E
,
Smida-Rezgui
S
,
Sarkozi
S
, et al.
Critical amino acid residues determine the binding affinity and the Ca2+ release efficacy of maurocalcine in skeletal muscle cells . J Biol Chem.
2003; ; 278 : :37822.-37831.
9.
Ram
N
,
Weiss
N
,
Texier-Nogues
I
, et al.
Design of a disulfide-less, pharmacologically inert, and chemically competent analog of maurocalcine for the efficient transport of impermeant compounds into cells . J Biol Chem.
2008; ; 283 : :27048.-27056.
10.
Konate
K
,
Crombez
L
,
Deshayes
S
, et al.
Insight into the cellular uptake mechanism of a secondary amphipathic cell-penetrating peptide for siRNA delivery . Biochemistry.
2010; ; 49 : :3393.-3402.
11.
Crombez
L
,
Charnet
A
,
Morris
MC
, et al.
A non-covalent peptide-based strategy for siRNA delivery . Biochem Soc Trans.
2007; ; 35 : :44.-46.
12.
Morris
MC
,
Depollier
J
,
Mery
J
, et al.
A peptide carrier for the delivery of biologically active proteins into mammalian cells . Nat Biotechnol.
2001; ; 19 : :1173.-1176.
13.
Pooga
M
,
Hallbrink
M
,
Zorko
M
,
Langel
U
. Cell penetration by transportan . FASEB J.
1998; ; 12 : :67.-77.
14.
Zhang
C
,
Tang
N
,
Liu
X
, et al.
siRNA-containing liposomes modified with polyarginine effectively silence the targeted gene . J Control Release.
2006; ; 112 : :229.-239.
15.
Radis-Baptista
G
,
de la Torre
BG
,
Andreu
D
. A novel cell-penetrating peptide sequence derived by structural minimization of a snake toxin exhibits preferential nucleolar localization . J Med Chem.
2008; ; 51 : :7041.-7044.
16.
Herbig
ME
,
Weller
K
,
Krauss
U
, et al.
Membrane surface-associated helices promote lipid interactions and cellular uptake of human calcitonin-derived cell penetrating peptides . Biophys J.
2005; ; 89 : :4056.-4066.
17.
Yeaman
MR
,
Yount
NY
. Mechanisms of antimicrobial peptide action and resistance . Pharmacol Rev.
2003; ; 55 : :27.-55.
18.
Deshayes
S
,
Plenat
T
,
Charnet
P
, et al.
Formation of transmembrane ionic channels of primary amphipathic cell-penetrating peptides. Consequences on the mechanism of cell penetration . Biochim Biophys Acta.
2006; ; 1758 : :1846.-1851.
19.
Henriques
ST
,
Castanho
MA
. Consequences of nonlytic membrane perturbation to the translocation of the cell penetrating peptide pep-1 in lipidic vesicles . Biochemistry.
2004; ; 43 : :9716.-9724.
20.
Binder
H
,
Lindblom
G
. Charge-dependent translocation of the Trojan peptide penetratin across lipid membranes . Biophys J.
2003; ; 85 : :982.-995.
21.
Conner
SD
,
Schmid
SL
Regulated portals of entry into the cell . Nature.
2003; ; 422 : :37.-44.
22.
Brasseur
R
,
Divita
G
. Happy birthday cell penetrating peptides: already 20 years . Biochim Biophys Acta.
2010; ; 1798 : :2177.-2178.
23.
Khafagy el
S
,
Morishita
M
,
Kamei
N
, et al.
Efficiency of cell-penetrating peptides on the nasal and intestinal absorption of therapeutic peptides and proteins . Int J Pharm.
2009; ; 381 : :49.-55.
24.
Elbashir
SM
,
Harborth
J
,
Lendeckel
W
, et al.
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells . Nature.
2001; ; 411 : :494.-498.
25.
Simeoni
F
,
Morris
MC
,
Heitz
F
,
Divita
G
. Peptide-based strategy for siRNA delivery into mammalian cells . Methods Mol Biol.
2005; ; 309 : :251.-260.
26.
Lundberg
P
,
El-Andaloussi
S
,
Sutlu
T
, et al.
Delivery of short interfering RNA using endosomolytic cell-penetrating peptides . FASEB J.
2007; ; 21 : :2664.-2671.
27.
Medarova
Z
,
Pham
W
,
Farrar
C
, et al.
In vivo imaging of siRNA delivery and silencing in tumors . Nat Med.
2007; ; 13 : :372.-377.
28.
Choi
YS
,
Lee
JY
,
Suh
JS
, et al.
The systemic delivery of siRNAs by a cell penetrating peptide, low molecular weight protamine . Biomaterials.
2011
(sous presse)..
29.
Muratovska
A
,
Eccles
MR
. Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells . FEBS Lett.
2004; ; 558 : :63.-68.
30.
Davidson
TJ
,
Harel
S
,
Arboleda
VA
, et al.. Highly efficient small interfering RNA delivery to primary mammalian neurons induces MicroRNA-like effects before mRNA degradation . J Neurosci.
2004; ; 24 : :10040.-10046.
31.
Choi
Y-S
,
Lee
JY
,
Suh
JS
, et al.
The systemic delivery of siRNAs by a cell penetrating peptide, low molecular weight protamine . Biomaterials.
2010; ; 31 : :1429.-1443.
32.
Crombez
L
,
Morris
MC
,
Dufort
S
, et al.
Targeting cyclin B1 through peptide-based delivery of siRNA prevents tumour growth . Nucleic Acids Res.
2009; ; 37 : :4559.-4569.
33.
Josephson
L
,
Tung
CH
,
Moore
A
,
Weissleder
R
. High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates . Bioconjug Chem.
1999; ; 10 : :186.-191.
34.
Jayagopal
A
,
Su
YR
,
Blakemore
JL
, et al.
Quantum dot mediated imaging of atherosclerosis . Nanotechnology.
2009; ; 20 : :165102..
35.
Sawicka
M
,
Kalinowska
M
,
Skierski
J
,
Lewandowski
W
. A review of selected anti-tumour therapeutic agents and reasons for multidrug resistance occurrence . J Pharm Pharmacol.
2004; ; 56 : :1067.-1081.
36.
Aroui
S
,
Ram
N
,
Appaix
F
, et al.
Maurocalcine as a non toxic drug carrier overcomes doxorubicin resistance in the cancer cell line MDA-MB 231 . Pharm Res.
2009; ; 26 : :836.-845.
37.
Aroui
S
. Maurocalcine as a non toxic drug carrier overcomes doxorubicin resistance in the cancer cell line MDA-MB 231 . Pharm Res.
2009; ; 26 : :836.-845.
38.
Liang
JF
,
Yang
VC
. Synthesis of doxorubicin-peptide conjugate with multidrug resistant tumor cell killing activity . Bioorg Med Chem Lett.
2005; ; 15 : :5071.-5075.
39.
Lindgren
M
,
Rosenthal-Aizman
K
,
Saar
K
, et al.
Overcoming methotrexate resistance in breast cancer tumour cells by the use of a new cell-penetrating peptide . Biochem Pharmacol.
2006; ; 71 : :416.-425.
40.
Niu
R
,
Zhao
P
,
Wang
H
et al.
Preparation, characterization, and antitumor activity of paclitaxel-loaded folic acid modified and TAT peptide conjugated PEGylated polymeric liposomes . J Drug Target.
2011
(sous presse).
41.
Olson
ES
,
Jiang
T
,
Aguilera
TA
, et al.
Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases . Proc Natl Acad Sci USA.
107 : :4311.-4316.
42.
Kersemans
V
,
Kersemans
K
,
Cornelissen
B
. Cell penetrating peptides for in vivo molecular imaging applications . Curr Pharm Des.
2008; ; 14 : :2415.-2447.
43.
Nguyen
QT
,
Olson
ES
,
Aguilera
TA
, et al.
Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival . Proc Natl Acad Sci USA.
107 : :4317.-4322.
44.
Su
W
,
Mishra
R
,
Pfeuffer
J
, et al.
Synthesis and cellular uptake of a MR contrast agent coupled to an antisense peptide nucleic acid: cell-penetrating peptide conjugate . Contrast Media Mol Imaging.
2007; ; 2 : :42.-49.
45.
Heitz
F
,
Morris
MC
,
Divita
G
Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics . Br J Pharmacol.
2009; ; 157 : :195.-206.
46.
Johnson
JL
,
Lowell
BC
,
Ryabinina
OP
, et al.
TAT-mediated delivery of a DNA repair enzyme to skin cells rapidly initiates repair of UV-induced DNA damage . J Invest Dermatol.
2011; ; 131 : :753.-761.
47.
Perea
SE
,
Reyes
O
,
Puchades
Y
, et al.
Antitumor effect of a novel proapoptotic peptide that impairs the phosphorylation by the protein kinase 2 (casein kinase 2) . Cancer Res.
2004; ; 64 : :7127.-7129.
48.
Khafagy el
S
,
Morishita
M
,
Takayama
K
The role of intermolecular interactions with penetratin and its analogue on the enhancement of absorption of nasal therapeutic peptides . Int J Pharm.
2010; ; 388 : :209.-212.
49.
Pooga
M
,
Kut
C
,
Kihlmark
M
, et al.
Cellular translocation of proteins by transportan . FASEB J.
2001; ; 15 : :1451.-1453.
50.
Chaubey
B
,
Tripathi
S
,
Ganguly
S
, et al.
A PNA-transportan conjugate targeted to the TAR region of the HIV-1 genome exhibits both antiviral and virucidal properties . Virology.
2005; ; 331 : :418.-428.
51.
Kim
DW
,
Jeong
HJ
,
Kang
HW
, et al.
Transduced human PEP-1-catalase fusion protein attenuates ischemic neuronal damage . Free Radic Biol Med.
2009; ; 47 : :941.-952.
52.
Morris
MC
,
Vidal
P
,
Chaloin
L
, et al.
A new peptide vector for efficient delivery of oligonucleotides into mammalian cells . Nucleic Acids Res.
1997; ; 25 : :2730.-2736.
53.
Crombez
L
,
Aldrian-Herrada
G
,
Konate
K
, et al.
A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells . Mol Ther.
2009; ; 17 : :95.-103.
54.
Hallbrink
M
,
Floren
A
,
Elmquist
A
, et al.
Cargo delivery kinetics of cell-penetrating peptides . Biochim Biophys Acta.
2001; ; 1515 : :101.-109.
55.
Harel-Bellan
A
. Prix Nobel de médecine 2006. Andrew Z. Fire et Craig C. Mello : silence, on désactive les gènes . Med Sci (Paris).
2006; ; 22 : :993.-994.
56.
Horcajada
P
,
Serre
C
,
Férey
G
, et al.
Des nanovecteurs hybrides pour la restitution retard de médicaments antitumoraux et antiviraux . Med Sci (Paris).
2010; ; 26 : :761.-767.
57.
Nicolas
MR
,
Moreau
M
. Prix Nobel de chimie 2008 (Osumo Shimomura, Martin Chalfie et Roger Y. Tsien) . Med Sci (Paris).
2008; ; 24 : :983.-984.